-transparent.png){kind=logo}
For the purpose of examining the transfer of anticancer drug into pancreatic juice and hepatic bile, 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) was given to 6 pancreaticoduodenectomized patients with periampullary cancer. The pancreatic juice and bile were collected through the pancreatic or biliary duct drainage before and after the intravenous administration of ACNU (2 mg/kg) for 210 minutes. ACNU concentrations of the pancreatic juice and hepatic bile reached to the maximum 15 minutes and 30 minutes after administration, respectively, and high transfer rates were sustained in both fluids. ACNU concentrations in the hepatic bile were higher than in the pancreatic juice in all cases.
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
August 1988,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
October 1993,
Gan to kagaku ryoho. Cancer & chemotherapy,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
August 1982,
Cancer,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
January 1994,
Journal of neuro-oncology,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
June 1985,
Journal of pharmacobio-dynamics,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
January 1980,
Cancer treatment reports,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
January 1981,
No shinkei geka. Neurological surgery,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
November 1987,
Cell biology international reports,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
July 1979,
Cancer research,
S Matsuno, and
K Kakizaki, and
K Sasaki, and
T Sato
September 2006,
Journal of neuro-oncology,
